Cision PR Newswire APAC
pressCenter
Innocan Pharma Announces Second Quarter Fiscal year 2026 Results, With Revenue of US$5.25M (CAD 7.3M)translating…
Second Quarter 2026 Results: Gross Margin of 90.9% and Category Leadership HERZLIYA, Israel and CALGARY, Alberta, Aug. 31, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ("Innocan" or the "Company"), today reported today 2026 financial consolidated…
Keywords#Innocan#Innocan Pharma#Second Quarter#Results#Announces